Studies of the application of selective P2Y2 (MRS2768) to activate mechanosensing pathways in vitro, ex vivo, and in vivo will increase our understanding of the involvement of P2Y2 in PAH pathomechanisms and offer new prospects and approaches for overcoming the disease. Here, P2RY2 is linked to pulmonary arterial hypertension.